ELTX

1.4503.33%
RT

Robert T. Connelly

CEO, President & Director

Mr. Robert T. Connelly, also known as Bob, has been Chief Executive Officer and Director of Elicio Therapeutics Inc. since October 2018 and serves as its President. He served as a Director of Anchiano Therapeutics Ltd since November 12, 2018 until December 31, 2019. He serves as a Director of Pronutria, Inc. He served as a Venture Partner of Flagship Pioneering since joining in 2013 until 2018. Mr. Connelly focused on providing strategic counsel and support to portfolio companies. Mr. Connelly Co-founded Incredible Foods, Inc. and served as its Chief Executive Officer. Mr. Connelly served as the Chief Executive Officer of Pulmatrix, Inc. from January 22, 2008 to September 4, 2012 and also served as its Advisor to the Chief Executive Officer. He joined Pulmatrix in January 2008 and led its efforts to conduct seven clinical trials in COPD, asthma and cystic fibrosis and introduced a novel drug delivery platform called iSPERSE with a pipeline of proprietary inhaled drugs. Since 2000, he served as a Founding Chief Executive Officer and First Employee of Domantis Limited. He served as the Chief Executive Officer of Veritas Pharmaceuticals, an early stage private US company with proprietary technology for the in vivo functional imaging of cancer and other diseases. Mr. Connelly spent over six years with Bioveris, Inc. At IGEN, he served as a Senior Vice President of Sales and Marketing and General Manager of IGEN's Life Sciences Business Unit. Mr. Connelly led IGEN’s efforts to develop, market and license novel detection technologies utilized in medical diagnostics and drug discovery and had a central role in IGEN’s financing activities. He had a central role in IGEN’s financing activities that raised more than 150 million in public financing during his tenure. Mr. Connelly began his career with the Medical Diagnostics Division of Abbott Laboratories, where he spending more than 11 years in sales, marketing and management and he left the firm in 1994. Mr. Connelly served as a Director at Pulmatrix, Inc. since January 2008. Mr. Connelly previously served on the boards of publicly traded life science companies Kaleido Biosciences, Inc. from 2015 to 2018. He served as an Executive Director of Domantis Limited. He served as the Chairman of AeroDesigns, Inc. He served as Director of Rainier Wines. He served as President and Chief Executive Officer of Axcella Health Inc. since June 2013 until May 2018. Prior to Axcella, Mr. Connelly served as the founding CEO of WikiCell Designs. He has served on the Board of Directors for Kaliedo and Kintai. He has experience starting, financing, building and managing companies in the life sciences, food and beverage and nutrition industries. He has raised over 200 million in venture capital financing for his companies, closed numerous transactions including license, platform technology, drug discovery, co-development, government and foundation funding and mergers and acquisitions partnerships and has launched many innovative products during his career. He received a B.S. in Business Administration from the University of Florida.

Positions